CVM
CEL-SCI·AMEX
--
--(--)
--
--(--)
CVM Profile
Cel-Sci Corporation
A company that develops immunotherapeutic agents and peptides to treat cancer and bacterial and viral infections
Biological Technology
03/22/1983
06/05/1997
American Stock Exchange
--
09-30
Common stock
8229 Boone Blvd.
Suite 802
Vienna
Virginia 22182
--
CEL-SCI Corporation was incorporated in Colorado on March 22, 1983 to fund research and development in the biomedical sciences, and ultimately to market and sell products. CEL-SCI Corporation is committed to research and development aimed at improving the treatment of cancer and other diseases by harnessing the immune system — the body's natural defense system. The company is currently working on Multikine, an investigational phase 3 immunotherapy for certain head and neck cancers, and L.E.A.P.S. (Ligand Epitope Antigen Reporting System) technology, including several product candidates for potential treatments for rheumatoid arthritis.
